Evidence map›Paper›PMID 38203266›Full record

ArticleInternational journal of molecular sciences2023

Novel Hydroxamic Acids Containing Aryl-Substituted 1,2,4- or 1,3,4-Oxadiazole Backbones and an Investigation of Their Antibiotic Potentiation Activity.

Anastasia A Zhukovets, Vladimir V Chernyshov, Aidar Z Al'mukhametov, Tatiana A Seregina, Svetlana V Revtovich, Mariia A Kasatkina, Yulia E Isakova, Vitalia V Kulikova, Elena A Morozova, Anastasia I Cherkasova and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Novel Small Molecule GLP-1R Agonists Based on 1Molecules (Basel, Switzerland) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Anastasia A ZhukovetsTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia.ORCID 0009-0001-5042-1773
Vladimir V ChernyshovTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia.ORCID 0000-0003-1347-4398
Aidar Z Al'mukhametovTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia.ORCID 0000-0002-3162-2801
Tatiana A SereginaEngelhardt Institute of Molecular Biology of the Russian Academy of Sciences, 32 Vavilov St., 119991 Moscow, Russia.ORCID 0000-0003-3278-0390
Svetlana V RevtovichEngelhardt Institute of Molecular Biology of the Russian Academy of Sciences, 32 Vavilov St., 119991 Moscow, Russia.ORCID 0000-0003-1594-9334
Mariia A KasatkinaTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia.
Yulia E IsakovaTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia.
Vitalia V KulikovaEngelhardt Institute of Molecular Biology of the Russian Academy of Sciences, 32 Vavilov St., 119991 Moscow, Russia.
Elena A MorozovaEngelhardt Institute of Molecular Biology of the Russian Academy of Sciences, 32 Vavilov St., 119991 Moscow, Russia.
Anastasia I CherkasovaTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia.ORCID 0000-0003-0236-2796
Timur A MannanovTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia.ORCID 0009-0006-5027-8539
Anastasia A AnashkinaEngelhardt Institute of Molecular Biology of the Russian Academy of Sciences, 32 Vavilov St., 119991 Moscow, Russia.ORCID 0000-0003-1763-300X
Pavel N SolyevEngelhardt Institute of Molecular Biology of the Russian Academy of Sciences, 32 Vavilov St., 119991 Moscow, Russia.ORCID 0000-0002-5546-4975
Vladimir A MitkevichEngelhardt Institute of Molecular Biology of the Russian Academy of Sciences, 32 Vavilov St., 119991 Moscow, Russia.ORCID 0000-0002-1517-1983
Roman A IvanovTranslational Medicine Research Center, Sirius University of Science and Technology, Olympic Ave. 1, 354340 Sochi, Russia.ORCID 0000-0002-9573-4183
Sirius University of Science and Technology · RUEngelhardt Institute of Molecular Biology · RU

Funding

Ministry of Science and Higher Education of the Russian Federation agreement № 075-10-2021-113, unique project ID RF----193021X0001
6 · The paper itself

Abstract

UDP-3-

Indexed as

Anti-Bacterial AgentsHydroxamic AcidsOxadiazolesEscherichia coliNalidixic AcidRifampin1,3,4-oxadiazoleAnti-Bacterial AgentsHydroxamic AcidsNalidixic AcidOxadiazolesRifampin1,2,4-oxadiazoles1,3,4-oxadiazolesantibacterial compoundsantibiotic potentiationgram-negative bacteriahydroxamic acidslipopolysaccharideLpxC

Identifiers

PMID38203266
PMCPMC10779255
OpenAlexW4389992249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.